Effect of Gender and Age on the Pharmacokinetics of Repinotan

被引：0
|
作者：
Roland Heinig
Pavur Sundaresan
Anita Shah
Michael Boettcher
机构：
[1] Bayer HealthCare AG,Institute of Clinical Pharmacology
[2] Bayer Pharmaceuticals Corporation,Department of Clinical Pharmacology
[3] Bayer Pharmaceuticals Corporation,Preclinical Drug Development
来源：
Clinical Drug Investigation | 2005年 / 25卷
关键词：
Dextromethorphan; Extensive Metaboliser; Debrisoquine; Metabolic Ratio; Sparteine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Repinotan hydrochloride (repinotan) is a selective, high-affinity, full serotonin receptor agonist at the 5-HT1a subtype that is undergoing clinical development in acute stroke. To investigate whether gender is an important covariable for repinotan pharmacokinetics, two studies were performed in subjects of different age and gender who had been phenotyped as extensive metabolisers for cytochrome P450 (CYP)2D6 using dextromethorphan as model substrate.
引用
收藏
页码：125 / 134
页数：9
相关论文
共 50 条
  • [31] EFFECT OF GENDER ON ANTIPYRINE PHARMACOKINETICS
    LUNA, BG
    SCAVONE, JM
    GREENBLATT, DJ
    LEDUC, BW
    PHARMACOTHERAPY, 1988, 8 (02): : 126 - 126
  • [32] THE EFFECTS OF AGE AND GENDER ON THE STEREOSELECTIVE PHARMACOKINETICS OF VERAPAMIL
    SASAKI, M
    TATEISHI, T
    EBIHARA, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (03) : 278 - 285
  • [33] INFLUENCE OF AGE ON THE PHARMACOKINETICS OF ALFENTANIL - GENDER DEPENDENCE
    LEMMENS, HJM
    BURM, AGL
    HENNIS, PJ
    GLADINES, MPPR
    BOVILL, JG
    CLINICAL PHARMACOKINETICS, 1990, 19 (05) : 416 - 422
  • [34] Impact of age and gender on the pharmacokinetics of gemtuzumab ozogamicin
    Korth-Bradley, JM
    Dowell, JA
    King, SP
    Liu, H
    Berger, MS
    PHARMACOTHERAPY, 2001, 21 (10): : 1175 - 1180
  • [35] EFFECTS OF AGE AND GENDER ON THE PHARMACOKINETICS OF VALPROATE AND PHENOBARBITAL
    Peng, W.
    Li, J.
    EPILEPSIA, 2013, 54 : 251 - 251
  • [36] The effects of age and gender on the pharmacokinetics of aripiprazole.
    Mallikaarjun, S
    Ali, MW
    Salazar, DE
    Bramer, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P66 - P66
  • [37] PHARMACOKINETICS OF TRIAZOLAM AND TEMAZEPAM - AGE AND GENDER EFFECTS
    SMITH, RB
    DIVOLL, M
    GILLESPIE, WR
    GREENBLATT, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 261 - 261
  • [38] AGE AND GENDER INFLUENCE THE STEREOSELECTIVE PHARMACOKINETICS OF PROPRANOLOL
    GILMORE, DA
    GAL, J
    GERBER, JG
    NIES, AS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 261 (03): : 1181 - 1186
  • [39] Pharmacokinetics of escalating doses of intravenous repinotan in healthy male volunteers
    Heinig, R
    Böttcher, MF
    CLINICAL DRUG INVESTIGATION, 2005, 25 (02) : 115 - 123
  • [40] Pharmacokinetics of a fixed dose and a weight-adjusted dose of IV repinotan
    Heinig, R
    Böttcher, M
    STROKE, 2004, 35 (06) : E287 - E287
12345